Literature DB >> 21440208

Multimarker panels in sepsis.

Brian Casserly1, Richard Read, Mitchell M Levy.   

Abstract

Biomarkers differentiate between 2 or more biologic states. The complexity of diseases like sepsis makes it unlikely that any single marker will allow for precise disease specification. Combining several biomarkers into a single classification rule should help to improve their accuracy and, therefore, their usefulness. This article reviews several studies using multimarker panels, and highlights the potential of more sophisticated diagnostic and prognostic techniques in future multimarker panels. More complex algorithms should accelerate the adoption of multimarker panels into the routine management of patients with sepsis, provided that clinicians understand the multimarker approach.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440208     DOI: 10.1016/j.ccc.2010.12.011

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  6 in total

1.  Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Authors:  Javier Benito; Carlos Luaces-Cubells; Santiago Mintegi; Eider Astobiza; Lorea Martinez-Indart; Ana Valls-Lafont; Juan-José García-García
Journal:  Eur J Pediatr       Date:  2013-06-22       Impact factor: 3.183

Review 2.  New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure.

Authors:  Francisco Valenzuela-Sánchez; Blanca Valenzuela-Méndez; Juan Francisco Rodríguez-Gutiérrez; Ángel Estella-García; María Ángela González-García
Journal:  Ann Transl Med       Date:  2016-09

3.  [Bacteremia and sepsis].

Authors:  S Hagel; M W Pletz; F M Brunkhorst; H Seifert; W V Kern
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

4.  Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study.

Authors:  Filippo Mearelli; Nicola Fiotti; Nicola Altamura; Michela Zanetti; Giovanni Fernandes; Ismet Burekovic; Alessandro Occhipinti; Daniele Orso; Carlo Giansante; Chiara Casarsa; Gianni Biolo
Journal:  Intern Emerg Med       Date:  2013-12-22       Impact factor: 3.397

Review 5.  Clinical application of sepsis biomarkers.

Authors:  Vinoth Sankar; Nigel R Webster
Journal:  J Anesth       Date:  2012-10-30       Impact factor: 2.078

6.  Plasma fractalkine is a sustained marker of disease severity and outcome in sepsis patients.

Authors:  Arie J Hoogendijk; Maryse A Wiewel; Lonneke A van Vught; Brendon P Scicluna; Hakima Belkasim-Bohoudi; Janneke Horn; Aeilko H Zwinderman; Peter M C Klein Klouwenberg; Olaf L Cremer; Marc J Bonten; Marcus J Schultz; Tom van der Poll
Journal:  Crit Care       Date:  2015-11-25       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.